Impacts of endostatin on expression of vascular endothelial growth factor receptor-2 in non-small cell lung cancer cells and mechanisms underlying its radiosensitizing effect
Liu Liang*,Liu Yi,Xia Youyou,Hu Chenxi,Qiao Yun,Wang Lei,Liu Bin,Chen Hui,Jiang Xiaodong
*Xuzhou Medical College Graduate Academy,Xuzhou 221006,China
Abstract：Objective To determine the effects of endostatin on the expression of vascular endothelial growth factor receptor-2(VEGFR-2) in non-small cell lung cancer cells (human A549 lung adenocarcinoma cells and human Calu-1 lung carcinoma cells), and to investigate the possible mechanisms underlying its radiosensitizing effect. Methods The CCK8 method was used to determine the inhibitory effect of endostatin on cell proliferation and calculate the drug concentration that caused a 20% reduction in cell proliferation within 24 h (IC20). RT-PCR and Western blot assays were used to assess the mRNA and protein expression of VEGFR-2, proteins within its related signaling pathways, and HIF-1α, respectively. The radiosensitivity of cells in each group was determined by colony formation assay;cell apoptosis and cell cycle distribution were determined by flow cytometry. Comparison of mean values between multiple samples was made by one-way analysis of variance, and comparison of mean values between two samples was made by t test. Results Endostatin significantly inhibited the proliferation of Calu-1 cells (F=50.36,P<0.01) with an IC20 of 296.5 μg/ml;the mRNA and protein expression of VEGFR-2 and HIF-1α was also significantly inhibited in endostatin-treated Calu-1 cells (F=25.43,10.44, all P<0.05). Moreover, the phosphorylation of Akt, ERK1/2, and p38 was significantly reduced in endostatin-treated Calu-1 cells (F=2.89,0.24,1.09, all P<0.05). The radiosensitivity enhancement ratios for Calu-1 cells and A549 cells were 1.38 and 1.09, respectively. Endostatin significantly induced apoptosis (F=44.15, P<0.01) and G2/M blockage (F=104.24,P<0.01) in Calu-1 cells. Conclusions Endostatin induces apoptosis and enhances radiosensitivity in Calu-1 cells with high expression of VEGFR-2, but it has a limited impact on A549 cells with low expression of VEGFR-2.
Liu Liang*,Liu Yi,Xia Youyou et al. Impacts of endostatin on expression of vascular endothelial growth factor receptor-2 in non-small cell lung cancer cells and mechanisms underlying its radiosensitizing effect[J]. Chinese Journal of Radiation Oncology, 2015, 24(5): 593-597.
[1] 傅华,许瑜,田仲泽,等.影响非小细胞肺癌脑转移患者放射治疗后生存的临床相关因素分析[J].中华肺部疾病杂志(电子版),2014,7(03):41-44.DOI:10.3877/cma.j.issn. 1674－6902. 2014.03.010. [2] 徐慧敏,曹建忠,王静波,等.非小细胞肺癌放疗后有症状放射性肺损伤临床特点分析[J].中华放射肿瘤学杂志,2013, 22(2):118-122.DOI:10.3760/cma.j.issn.1004-4221.2013.02.009. [3] Hiroyuki T,Masabumi S.The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions[J]. Clin Sci (Lond),2005,109(3):227-241. [4] Anne S,Antoine S,Lo Cristiana N,et al. Combination of bevacizumab and irradiation on uveal melanoma:an in vitro and in vivo preclinical study[J]. Invest New Drugs,2013,31(1):59-65.DOI:10.1007/s10637-012-9834-6. [5] Giatromanolaki A,Koukourakis M,Sivridis E,et al. Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer[J].Eur J Clin Invest,2007,37(11):878-886. [6] Jiang XD,Ding MH,Qiao Y,et al. Study on lung cancer cells expressing VEGFR2 and the impact on the effect of RHES combined with radiotherapy in the treatment of brain metastases[J].Clin Lung Cancer,2014,15(2):23-29.DOI:10.1016/j.cllc.2013.11.012. [7] Donnem T,Al-Shibli K,Andersen S,et al. Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer[J].Cancer,2010,116(18):4318-4325.DOI:10.1002/cncr.25333. [8] Yang F,Tang XM,Erick R,et al. Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapy[J].Cancer Res,2011,71(16):5512-5521.DOI:10.1158/0008－5472.CAN-10-2614. [9] Young-Mi K,Sewook H,Young-Myoeng K,et al. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1[J].J Biol Chem,2002,277(31):27872-27879.DOI:10.1074/jbc. M202771200. [10] 张莹,蒋晓东,乔云,等.不同肺癌细胞株中VEGFR-2 mRNA表达的实验研究[J].临床肿瘤学杂志,2013,18(10)879-881.DOI:10.3969/j.issn.1009-0460.2013.10.004. [11] Qingdong K,Max C.Hypoxia-inducible factor-1(HIF-1).Mol Pharmacol,2006,70(5):1469-1480.DOI:10.1124/mol.106.027029. [12] Meijer-Tineke WH,Kaanders-Johannes HAM,Span-Paul N,et al. Targeting hypoxia,HIF-1,and tumor glucose metabolism to improve radiotherapy efficacy[J].Clin Cancer Res,2012,18(20):5585-5594.DOI:10.1158/1078－0432.CCR-12-0858. [13] Faton A,Bing-Hua J.Oxygen-independent regulation of HIF-1:novel involvement of PI3K/AKT/mTOR pathway in cancer[J].Curr Cancer Drug Targets,2013,13(3):245-251.DOI:10.2174/1568009611313030003. [14] Athanasios K, Antonis G,Maria P,et al. Biochemical and molecular analysis of the interaction between ERK2 MAP kinase and hypoxia inducible factor-1α[J].Int J Biochem Cell Biol,2011,43(11):1582-1590.DOI:10.1016/j.biocel.2011.07.007. [15] Sodhi A,Montaner S,Patel V,et al. The Kaposi′s sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha[J].Cancer Res,2000,60(17):4873-4880.
2015, Vol. 24 
